Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nasaruplase beta - Microbix

Drug Profile

Nasaruplase beta - Microbix

Alternative Names: A-74187; ABT 187; MRX-515; PROLYSE; r-ProUK

Latest Information Update: 29 Aug 2012

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Abbott Laboratories
  • Class Anti-ischaemics; Plasminogen activator enzymes; Serine endopeptidases; Thrombolytics
  • Mechanism of Action Fibrinolytic agents; Plasminogen activators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Peripheral vascular disorders; Stroke

Most Recent Events

  • 31 Dec 2009 Discontinued - Phase-III for Stroke in Canada (IV)
  • 31 Dec 2009 Discontinued - Phase-III for Stroke in USA (IV)
  • 24 Sep 2008 Microbix Biosystem Inc acquires urokinase protfolio from ImaRx Therapeutics Inc ,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top